Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v3-FR
Language English French
Date Updated 2023-05-19 2023-04-13
Drug Identification Number 02502348 02502348
Brand name SUBOXONE SUBOXONE
Common or Proper name SUBOXONE SUBLINGUAL FILM 8MG/2MG 30S CA SUBOXONE SUBLINGUAL FILM 8MG/2MG 30S CA
Company Name INDIVIOR UK LIMITED INDIVIOR UK LIMITED
Ingredients NALOXONE BUPRENORPHINE NALOXONE BUPRENORPHINE
Strength(s) 2MG 8MG 2MG 8MG
Dosage form(s) FILM, SOLUBLE FILM, SOLUBLE
Route of administration SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL
Packaging size 30 film strips/pack 30 film strips/pack
ATC code N07BC N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-04-17 2023-04-17
Actual start date
Estimated end date 2023-05-31 2023-05-31
Actual end date 2023-05-18
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments